HAMILTON CHRISTINE E received a stock award from SAB BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/9/2022ACC: 0001209191-22-060501
Director10% Owner
Since Oct 2021
+165.97K
Net shares
Net buyer
$100.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
165.97K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+82.99K
Price / share
$1.21
Trade value
$100K
% of position
2.7%
12/7/2022
3.03M→3.11M
Total
Net shares
+82.99K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/7/2022 | A · Award | +82.99K | $1.21 | $100K | 2.7% | 3.03M | 3.11M |
| Total | +82.99K | $100K | ||||||
Derivative Transactions1
Warrant (Common Stock)
Indirect
Converts to
Common Stock
82.99K shares
Shares
+82.99K
Strike price
1.08
Held after
82.99K
Exercisable
—
12/7/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (Common Stock) Indirect | Common Stock82.99K shares | 12/7/2022 | A · Award | +82.99K | 1.08 | — | 82.99K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned4.99M
Total
4.99M direct4.99M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.99M | Direct |
| Total | 4.99M | 4.99M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported